Bruker Announces Acquisition of MOLECUBES NV

Expands Nuclear Molecular Imaging Portfolio with Modular Benchtop CUBES™ PET, SPECT and CT Preclinical Imaging Systems GHENT, Belgium–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) today announced the acquisition of MOLECUBES NV, a dynamic innovator in benchtop preclinical nuclear molecular imaging (NMI) systems. This acquisition strengthens Bruker’s position as a leading NMI solutions provider in preclinical and... Read more